Article: Artimplant Interim Report January - September 2009.

VASTRA FROLUNDA, Sweden -- Regulatory News:

Artimplant (STO:ARTIB):

* Net revenue for the third quarter increased to SEK 5.5 million (2.3) and for January-September to SEK 18.2 million (7.5)*

* The net loss for the third quarter totaled SEK 4.7 million (4.3) and for January-September SEK 13.2 million (16.6)

* Earnings per share for the third quarter amounted to SEK -0.08 (-0.07) and for January-September SEK -0.22 (-0.28)

* Sales of Artelon[R] Spacer for the third quarter increased to SEK 2.5 million (1.2) and for January-September to SEK 10.7 million (4.9)

* Sales of Artelon[R] Tissue Reinforcement for the third ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!